Color LCD Display, Model Radiforce R22
510(k) K033466
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK033466 | Date20 Feb 2004 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LLZ
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.2050
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 27 Sep 2026
The device is a color LCD display, model Radiforce R22, as specified in the device name and specifications. It is a Class II X-ray system used in radiology, as indicated by the advisory committee classification and device type context.
The device received FDA 510(k) clearance under K-number K033466 on February 20, 2004, and is substantially equivalent to a predicate device. It is manufactured by Eizo Nanao Corporation and supplied as a reusable monitor for radiology imaging review, with no claims made about sterility, single-use status, MRI safety, sizes, or storage conditions beyond what is explicitly stated in the data.
Other devices from Eizo Nanao Corporation
Questions
AI-generated answers, 27 Sep 2026
What is the Eizo Radiforce R22 used for?
The Eizo Radiforce R22 is a color LCD display used in radiology for reviewing medical imaging, as indicated by its classification under the Radiology advisory committee and its intended use as a monitor for radiology imaging review.
Is the Eizo Radiforce R22 a single-use or reusable device?
The Eizo Radiforce R22 is supplied as a reusable monitor for radiology imaging review, with no claims made about single-use status, meaning it is designed for repeated use in clinical settings.
How was the Eizo Radiforce R22 cleared for market?
The Eizo Radiforce R22 received FDA 510(k) clearance under K-number K033466 on February 20, 2004, based on a determination of substantial equivalence to a predicate device, which is the regulatory pathway indicated in the device data.